SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-012810
Filing Date
2023-08-02
Accepted
2023-08-02 07:16:05
Documents
14
Period of Report
2023-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K edit-20230802x8k.htm   iXBRL 8-K 33062
2 EX-99.1 edit-20230802xex99d1.htm EX-99.1 93126
3 GRAPHIC edit-20230802xex99d1001.jpg GRAPHIC 6224
  Complete submission text file 0001558370-23-012810.txt   262234

Data Files

Seq Description Document Type Size
4 EX-101.SCH edit-20230802.xsd EX-101.SCH 3148
5 EX-101.LAB edit-20230802_lab.xml EX-101.LAB 15238
6 EX-101.PRE edit-20230802_pre.xml EX-101.PRE 9829
8 EXTRACTED XBRL INSTANCE DOCUMENT edit-20230802x8k_htm.xml XML 4626
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 231133716
SIC: 2836 Biological Products, (No Diagnostic Substances)